The 8th Annual Immuno-Oncology and Cell Therapy meeting will bring together industry thought leaders from pharmaceutical and biotech companies and .. Read more leading clinical centers to discuss emerging immuno-oncology targets, next-generation immunotherapies, combination strategies, and advances in cell therapy. While cancer immunotherapy has made a giant leap in the past decade, the majority of therapies at advanced stages of development are clustered in a similar target and mechanism space. The increased investment in immuno-oncology has created an urgent opportunity to discover and populate new target spaces and develop new modalities that either present new classes of immunotherapies or can be used in combination with existing products. All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
- Share your Experience
More Events From The Organizer
- Immuno-Oncology Biomarkers16 - 17 Feb 2021Online